Related Experiment Video
Updated: May 6, 2026

07:49
Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
10.1K
MiR-134-mediated β1 integrin expression and function in mesenchymal stem cells.
David M Poitz1, Friedrich Stölzel2, Laleh Arabanian2
1Department of Internal Medicine and Cardiology, University of Technologies Dresden, Germany.
Biochimica Et Biophysica Acta
|October 19, 2013
Summary
MicroRNA-134 (miR-134) negatively regulates beta-1 integrin (β1 integrin) expression in mesenchymal stem cells (MSCs), impacting cell adhesion. This finding is significant for understanding myelodysplastic syndromes (MDS).
Area of Science:
- Hematology
- Molecular Biology
- Cell Biology
Background:
- The hematopoietic stem cell (HSC) niche is crucial for HSC properties and is regulated by molecules like integrins.
- Integrins mediate interactions between HSCs and mesenchymal stem cells (MSCs) within the bone marrow niche.
Purpose of the Study:
- To investigate the role of miR-134 in regulating integrin expression within MSCs.
- To elucidate the mechanism of miR-134's action on integrin expression and its functional consequences.
Main Methods:
- Post-transcriptional regulation analysis of beta-1 integrin (β1 integrin) by miR-134 in MSCs.
- Atomic force microscopy to assess cell adhesion changes after miR-134 transfection.
- Comparison of miR-134 and β1 integrin expression in MSCs from myelodysplastic syndrome (MDS) patients and healthy donors.
Main Results:
- miR-134 directly binds to the 3' untranslated region of β1 integrin mRNA, leading to its post-transcriptional silencing.
- miR-134 overexpression in MSCs reduced the adhesion of 32D cells to MSCs and decreased MSC adhesion to fibronectin.
- MSCs from MDS patients exhibited significantly higher miR-134 levels and lower β1 integrin protein expression compared to healthy controls.
Conclusions:
- miR-134 acts as a negative regulator of β1 integrin expression in MSCs, influencing cell adhesion.
- The dysregulation of miR-134 and β1 integrin in MDS-derived MSCs contributes to the understanding of MDS pathogenesis.
Related Concept Videos
Mesenchymal Stem Cells
4.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K
Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
Activation of Integrins
4.4K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
4.4K

